PMID- 21068541 OWN - NLM STAT- MEDLINE DCOM- 20110321 LR - 20211020 IS - 1554-8635 (Electronic) IS - 1554-8627 (Print) IS - 1554-8627 (Linking) VI - 7 IP - 1 DP - 2011 Jan TI - DAMP-mediated autophagy contributes to drug resistance. PG - 112-4 AB - Damage-associated molecular pattern molecules (DAMPs) are cellularly derived molecules that can initiate and perpetuate immune responses following trauma, ischemia and other types of tissue damage in the absence of pathogenic infection. High mobility group box 1 (HMGB1) is a prototypical DAMP and is associated with the hallmarks of cancer. Recently we found that HMGB1 release after chemotherapy treatment is a critical regulator of autophagy and a potential drug target for therapeutic interventions in leukemia. Overexpression of HMGB1 by gene transfection rendered leukemia cells resistant to cell death; whereas depletion or inhibition of HMGB1 and autophagy by RNA interference or pharmacological inhibitors increased the sensitivity of leukemia cells to chemotherapeutic drugs. HMGB1 release sustains autophagy as assessed by microtubule-associated protein 1 light chain 3 (LC3) lipidation, redistribution of LC3 into cytoplasmic puncta, degradation of p62 and accumulation of autophagosomes and autolysosomes. Moreover, these data suggest a role for HMGB1 in the regulation of autophagy through the PI3KC3-MEKERK: pathway, supporting the notion that HMGB1-induced autophagy promotes tumor resistance to chemotherapy. FAU - Liu, Liying AU - Liu L AD - Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China. FAU - Yang, Minghua AU - Yang M FAU - Kang, Rui AU - Kang R FAU - Wang, Zhuo AU - Wang Z FAU - Zhao, Yiming AU - Zhao Y FAU - Yu, Yan AU - Yu Y FAU - Xie, Min AU - Xie M FAU - Yin, Xiaocheng AU - Yin X FAU - Livesey, Kristen M AU - Livesey KM FAU - Loze, Michael T AU - Loze MT FAU - Tang, Daolin AU - Tang D FAU - Cao, Lizhi AU - Cao L LA - eng PT - Journal Article DEP - 20110101 PL - United States TA - Autophagy JT - Autophagy JID - 101265188 RN - 0 (HMGB1 Protein) RN - 0 (Receptors, Pattern Recognition) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) SB - IM MH - *Autophagy MH - *Drug Resistance, Neoplasm MH - HMGB1 Protein/metabolism MH - Humans MH - Leukemia/enzymology/pathology MH - MAP Kinase Signaling System MH - Models, Biological MH - Phosphatidylinositol 3-Kinases/metabolism MH - Receptors, Pattern Recognition/*metabolism PMC - PMC3039734 EDAT- 2010/11/12 06:00 MHDA- 2011/03/22 06:00 PMCR- 2011/01/01 CRDT- 2010/11/12 06:00 PHST- 2010/11/12 06:00 [entrez] PHST- 2010/11/12 06:00 [pubmed] PHST- 2011/03/22 06:00 [medline] PHST- 2011/01/01 00:00 [pmc-release] AID - 14005 [pii] AID - 1554-8627-7-1-19 [pii] AID - 10.4161/auto.7.1.14005 [doi] PST - ppublish SO - Autophagy. 2011 Jan;7(1):112-4. doi: 10.4161/auto.7.1.14005. Epub 2011 Jan 1.